Key facts
- BIOS Fund III, LP filed SCHEDULE 13G/A for Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD).
- Disclosed ownership: 4.5%.
- Date of event: 12 May 2026.
BIOS Fund III, LP - 12 May 2026 SCHEDULE 13G/A Report for Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD)
- Filing Manager
- BIOS Fund III, LP
- Reporting Manager
- AARON G.L. FLETCHER
- Symbol
- IRD
- Shares outstanding
- 81,311,898 shares
- Disclosed Ownership
- 3,683,429 shares
- Ownership
- 4.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 May 2026, 11:07:52 UTC
- Date of event
- 12 May 2026
- SEC
- View on sec.gov
Key filing fact
BIOS Fund III, LP disclosed 4.5% ownership in Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD) on 12 May 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 May 2026, 11:07.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (10)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AARON G.L. FLETCHER | 4.5% | 3,683,429 | 0 | 3,683,429 | /s/ John Fucci | John Fucci, as Attorney-in-Fact for Aaron G.L. Fletcher | |
| BIOS ADVISORS GP, LLC | 4.5% | 3,683,429 | 0 | 3,683,429 | /s/ John Fucci | John Fucci/Attorney-in-Fact | |
| BIOS CAPITAL MANAGEMENT, LP | 4.5% | 3,683,429 | 0 | 3,683,429 | /s/ John Fucci | John Fucci/Attorney-in-Fact | |
| BIOS EQUITY PARTNERS III, LP | 4.5% | 3,683,429 | 0 | 3,683,429 | /s/ John Fucci | John Fucci/Attorney-in-Fact | |
| BIOS FUND III, LP | 0.53% | 430,665 | 0 | 430,665 | /s/ John Fucci | John Fucci/Attorney-in-Fact | |
| BIOS FUND III NT, LP | 0.55% | 450,811 | 0 | 450,811 | /s/ John Fucci | John Fucci/Attorney-in-Fact | |
| BIOS FUND III QP, LP | 3.4% | 2,801,953 | 0 | 2,801,953 | /s/ John Fucci | John Fucci/Attorney-in-Fact | |
| CAVU ADVISORS, LLC | 4.5% | 3,683,429 | 0 | 3,683,429 | /s/ John Fucci | John Fucci/Attorney-in-Fact | |
| CAVU MANAGEMENT, LP | 4.5% | 3,683,429 | 0 | 3,683,429 | /s/ John Fucci | John Fucci/Attorney-in-Fact | |
| LESLIE W. KREIS | 4.5% | 3,683,429 | 0 | 3,683,429 | /s/ John Fucci | John Fucci, as Attorney-in-Fact for Leslie W. Kreis, Jr. |
CIK / CUSIP context first